Blog

We Handed Primary Care an Impossible Job

Written by Elli Kaplan | Nov 17, 2026, 4:44:50 PM

The confidence gap in cognitive care is a system design problem, and I think it is worth being honest about how it got built.

Half of primary care physicians report that they do not feel adequately prepared to act on suspected cognitive decline. That statistic is easy to read as a training problem, or a buy-in problem, or a workflow discipline problem. Something that better education or a firmer mandate could fix.

I have never found that reading convincing. To me it looks like the predictable result of asking primary care to do something ambitious without giving them the tools or resources to do it well.

The job primary care was handed

For years, external pressures have assigned primary care physicians a job that sounds simple enough on paper: catch cognitive decline early, at the annual wellness visit if possible, and before a patient or a family member has to raise the concern themselves. It’s obvious why the ask keeps getting made. Early identification is when intervention has the most room to work, and CMS increasingly expects that work to happen there.

It is also a request that sits on top of everything else primary care is already carrying for the same patient. Cognitive care is rarely one screening item, since it means managing the biology, watching for behavioral change, and coaching the family, all of it alongside diabetes, cardiovascular risk, medication reconciliation, fall risk, and depression screening. Adding the hardest of those to a visit that is already full is a bigger request than it sounds.

It is worth being specific about what catching it early requires. A clinician has to detect a signal that is by definition subtle, in a domain that does not show up on a blood pressure cuff or a standard lab panel, during a visit that is already full.

One thing here has genuinely changed. We now have blood tests that can indicate Alzheimer's pathology, and they are a real advance for the field. But those tests describe what is happening biologically, and dementia is still diagnosed on how a person is functioning day to day. Our Chief Science Officer, Russell Banks, wrote about this in more detail recently, and the short version is that blood work raises the value of cognitive assessment rather than replacing it.

Primary care is tasked with finding the earliest, hardest-to-detect signal in medicine, inside the shortest, most crowded visit in medicine, using outdated instruments.

Why the old cognitive tools fall short

The MMSE, Mini-Cog, and MoCA remain the most widely used cognitive tools in primary care today. They were developed between 1975 and 2005, which means they predate the EHR, the smartphone, and any expectation that a clinician might need a result in four minutes, scored automatically and documented directly into the chart.

They also were not built for the range where the hardest decisions now live. Many patients with amnestic MCI score within the normal range on the MMSE despite measurable, real decline, which is less a misuse of the tool than a structural limit of what it was designed to catch. The Cochrane review of the MMSE said as much, finding no evidence to support the test as a standalone way to identify which patients with MCI will go on to develop dementia.

Then there is time. A standard annual wellness visit runs about 40 minutes, and its checklist is full before cognition enters the conversation. The paper tools can take up to 20 minutes to administer and score by hand, and that arithmetic has not worked for a long time.

And even when a physician does get a concerning result, the path forward is often undefined. Referral workflows sit outside the system, care plans get built from scratch, and the loop with the specialist or the family closes informally or not at all. Without a defined next step attached to it, a concerning score does not lead anywhere.

How the detection gap took shape

Given all of that, the numbers look about like you would expect:

  • An estimated 92 percent of expected MCI cases in the Medicare population go undiagnosed
  • Roughly 80 percent of adults 65 to 80 are not receiving routine cognitive screening at all
  • Up to 61 percent of people currently living with dementia remain undiagnosed

These numbers get discussed as a detection gap, and they are one. But they are downstream of a design gap that came first. You cannot hand someone an outdated instrument, a compressed visit, and no pathway forward, and then be surprised when the system underperforms. By the time the problem surfaces in figures like these it reads as a clinical shortfall, when it began as a question of what primary care was given to work with.

Why an early diagnosis matters more than it used to

We now have two FDA-approved therapies that only work in patients diagnosed at the MCI or early stage. Neither is effective in moderate or advanced disease, which means every patient who reaches a later stage without an earlier diagnosis may have been eligible for treatment and simply was not found in time. Whether a patient can access treatment at all now depends on whether they are found early enough.

At the same time, CMS-HCC V28 has changed how dementia gets documented and reimbursed, splitting dementia into three severity tiers and rewarding the clinical specificity that current tools and workflows were never built to produce. For the first time in dementia care the financial incentives and the clinical incentives point in the same direction, which leaves infrastructure as the remaining obstacle.

The physicians I have spent time with in this field are not reluctant to engage with cognitive health. They are asking, reasonably, to be equipped to do it well.

What would actually equip primary care

Equipping primary care properly means giving them instruments sensitive enough to catch what the old ones miss, fast enough to fit inside the visit that already exists, and connected to a defined path forward once a result comes back. Asking physicians to do more with the same tools is never going to close this gap.

That is the problem Neurotrack was built to solve, and it is why we describe ourselves as a cognitive care enablement platform. We pair clinically validated assessments that fit inside a four to eight minute window with Smart Logic™, which draws on a patient's full EHR context to help a clinician move from a result to a structured, patient-specific care plan.

None of that replaces clinical judgment, and none of it should. The clinician still makes the diagnosis and still makes the decisions. What changes is whether they are doing that with the tools the job actually requires, or the tools they were handed fifty years before the job changed.

Primary care did not create this gap, and they should not be expected to close it alone.